"Long-acting biologics represent a true revolution in the treatment of asthma and nasal polyposis. Investing in innovation and pharmacological research means improving the quality of life of our patients." This was stated by Simona Loizzo, member of the XII Social Affairs Committee of the Chamber of Deputies, attending the institutional conference organized by the Longevitas Foundation with the unconditional contribution of GSK, at the Auditorium of the Ministry of Health in Rome.
Health, Loizzo (Lega): "More innovation and research for patients with severe asthma and nasal polyps."

"Long-acting biologics represent a true revolution in the treatment of asthma and nasal polyps. Investing in innovation and pharmacological research means improving the quality of life of our patients," said Simona Loizzo, member of the XII Social Affairs Commission at the...